|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 444.92 USD | -0.03% |
|
-0.43% | -1.86% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 548.69 | +23.32% | 29 | ||||||
| 1,215.79 | +7.31% | 29 | ||||||
| 252.87 | +4.98% | 23 | ||||||
| 253.55 | +11.34% | 29 | ||||||
| 360.76 | +9.32% | 17 | ||||||
| 154.88 | +0.97% | 21 | ||||||
| 220.99 | +22.3% | 21 | ||||||
| 311.78 | +8.54% | 23 | ||||||
| 352.5 | -0.76% | 30 | ||||||
| 157.57 | +25.46% | 28 | ||||||
| 29.19 | +11.36% | 27 | ||||||
| 63.08 | +10.41% | 25 | ||||||
| 96.7 | +26.26% | 23 | ||||||
| 20.77 | +4.67% | 19 | ||||||
| 9,973.33 | +33.87% | 15 | ||||||
| 6,136.87 | +20.76% | 15 | ||||||
| 81.26 | +67.59% | 16 | ||||||
| 49.5 | +36.78% | 19 | ||||||
| 40.9 | +18.11% | 10 | ||||||
| Average | 1,069.53 | +18.03% | 22 | ||||||
| Weighted average by Cap. | 706.22 | +11.19% | 25 |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
